Cannabis-Related Disorders and Toxic Effects
NEJM 389: 2267-2275, Gorelick,D.A., 2023
Prevalence of Cannabis Withdrawal Symptoms Among People with Regular or Dependent Use of Cannabinoids
JAMA doi:10.1001/JAMANETWORKOPEN.2020.2370, Bahji, A.,et al, 2020
Clinical Features of Dopamine Agonist Withdrawal Syndrome in a Movement Disorders Clinic
JNNP 84:130-135, Pondal, M.,et al, 2013
"Bath Salts" Intoxication
NEJM 365:967-968, Ross, E.A.,et al, 2011
Dopamine Agonist Withdrawal Syndrome in Parkinson Disease
Arch Neurol 67:58-63, Rabinak,C. &Nirenberg,M., 2010
Transient Lesion in the Splenium of the Corpus Callosum and Antiepileptic Drug Withdrawal
Neurol 65:1032-1036, Gurtler,S.,et al, 2005
Management of Drug and Alcohol Withdrawal
NEJM 348:1786-1795, Kosten,T.R. &O'Connor,P.G., 2003
Clinical Features of Withdrawal Headache Following Overuse of Triptans and Other Headache Drugs
Neurol 57:1694-1698, Katsarava,Z.,et al, 2001
Use of Benzodiazepines in Anxiety Disorders
NEJM 328:1398-1405, Shader,R.I.&Greenblatt,D.J., 1993
Withdrawal Syndrome after the Double-Blind Cessation of Caffeine Cunsumption
NEJM 327:1109-1114, 11601992., Silverman,R.,et al, 1992
Risk Associated with Heparin Withdrawal in Ischaemic Cerebrovascular Disease
JNNP 52:1332-1336, Slivka,A.,et al, 1989